A case of complete response to gemcitabine+nab-paclitaxel therapy for pleomorphic cell type anaplastic pancreatic cancer with liver metastasis

Key Points

• This case report aims to illustrate the effectiveness of gemcitabine and nab-paclitaxel therapy on anaplastic pancreatic cancer with liver metastasis.
• Diagnosis was confirmed via ultrasound endoscopic fine-needle aspiration.
• Aged 80 male patient received gemcitabine and nab-paclitaxel therapy for six cycles.
• Follow-up imaging was conducted post-therapy to assess for tumor response.
• Complete disappearance of primary tumor and liver metastases observed after six treatment cycles.
• Grade 2 peripheral neuropathy noted during therapy, but overall the patient tolerated treatment well.
• Patient remained free of recurrence for 7 years and 8 months after therapy cessation.